Apricus Biosciences (APRI) +12.5% premarket after announcing it has licensed Takeda...

|About: Apricus Biosciences, Inc (APRI)|By:, SA News Editor

Apricus Biosciences (APRI) +12.5% premarket after announcing it has licensed Takeda Pharmaceuticals (TKPHF.PK, TKPYY.PK) to market Vitaros, its erectile dysfunction drug, in the U.K. Takeda will pay APRI an undisclosed upfront payment and milestone payments of up to 35M euros.